Similar articles

• Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.

  Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A. Fischer HD, et al. Arch Intern Med. 2010 Apr 12;170(7):617-21. doi: 10.1001/archinternmed.2010.37. Arch Intern Med. 2010. PMID: 20386005
• Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.

  Roustit M, Blondel E, Villier C, Fonrose X, Mallaret MP. Roustit M, et al. Ann Pharmacother. 2010 Apr;44(4):764-7. doi: 10.1345/aph.1M597. Epub 2010 Mar 2. Ann Pharmacother. 2010. PMID: 20197475
• Quality improvement case study: warfarin sodium interactions.

  Weinberg AD, Altman JS, Pals JK. Weinberg AD, et al. J Am Med Dir Assoc. 2006 Jun;7(5):315-8. doi: 10.1016/j.jamda.2006.04.004. J Am Med Dir Assoc. 2006. PMID: 16765868 Review.
• A rare occurrence of trimethoprim/sulfamethoxazole (TMP/SMX)-induced aseptic meningitis in an older woman.

  Andrade A, Hilmas E, Walter C. Andrade A, et al. J Am Geriatr Soc. 2000 Nov;48(11):1537-8. J Am Geriatr Soc. 2000. PMID: 11083344 No abstract available.
• Interaction of vitamin K antagonists and trimethoprim-sulfamethoxazole: ignore at your patient's risk.

  Hale SF, Lesar TS. Hale SF, et al. Drug Metabol Drug Interact. 2014;29(1):53-60. doi: 10.1515/dmdi-2013-0049. Drug Metabol Drug Interact. 2014. PMID: 24231121 Review.